Dipsacus: A Comprehensive Encyclopedic Reference
1. Identity, Taxonomy, and Nomenclature
Dipsacus is a genus of flowering plants belonging to the family Caprifoliaceae (formerly placed in the now-defunct family Dipsacaceae). The genera Dipsacus L. and Scabiosa L. of the Caprifoliaceae family are widely distributed in Europe, Asia, and Africa. The genus comprises multiple species of medicinal relevance, of which two are most extensively studied and used: Dipsacus asper Wall. ex C.B. Clarke (also referred to as D. asperoides C.Y. Cheng & T.M. Ai, depending on taxonomic authority) and Dipsacus fullonum L.
Dipsacus asper Wall. ex C.B. Clarke (DA), also named Xu-Duan in Chinese, is a species in the genus Dipsacus (family Caprifoliaceae). The Chinese name Xu Duan (续断) translates roughly as "renewing fractures" or "restoring what is broken," a reference to one of its primary traditional applications. Dipsacus asper Wall. ex Henry was first reported in the Shennong Materia Medica, and is the dried root of the perennial plant known as Sichuan teasel.
In pharmacy and herbal medicine, the official drug material derived from this plant is designated Radix Dipsaci (also written Dipsaci Radix or abbreviated DR or RD). Dipsacus asperoides, which belongs to the small plant family Caprifoliaceae, is a perennial herb that grows in moist fields and mountains. Radix Dipsaci, also named Xu Duan or Himalayan Teasel Root, is the dried root of Dipsacus asperoides C.Y. Cheng & T.M.Ai.
Another species of Dipsacus is D. fullonum L., commonly known as teasel or wild teasel. Traditionally, D. fullonum has been used to treat Lyme disease and eye infections in cattle. D. fullonum is distributed naturally in Europe. A rich source of valuable ingredients used in the traditional medicine of the Kashmir Himalayas is D. inermis Wall., also known as Wopal haakh/Wopal Hak in the Kashmiri language. It is used in treating cold, fever, cough, sore throat, general fatigue, and body pain and has demonstrated stomachic and carminative properties.
1.1 Pharmacopoeial Recognition
The genus Dipsacus has been used for centuries in Chinese and Korean folk medicines to treat bone (osteoporosis) and joint problems (rheumatic arthritis). The Korean Herbal Pharmacopoeia and Chinese Pharmacopoeia include Dipsaci radix, the dried roots of D. asperoides C.Y.Cheng & T.M.Ai. In the 2015 edition of Chinese Pharmacopoeia, TLC and HPLC methods, moisture content, total ash, acid-insoluble ash, and ethanol extract had been used for comprehensive quality control of DA. The Chinese Pharmacopoeia specifies a minimum asperosaponin VI content as a Dipsacus asper Wall quality standard.
1.2 Common Names and Synonyms
- Chinese: Xu Duan (续断); Chuan Duan
- Pharmaceutical: Radix Dipsaci, Dipsaci Radix
- English common names: Teasel root, Himalayan teasel root, Sichuan teasel root, rough teasel (D. asper); wild teasel, Fuller's teasel, common teasel (D. fullonum)
1.3 Geographic Distribution and Cultivation
In China, D. asper is mainly produced in Sichuan, Hubei, Hunan and Guizhou, with the highest production in Sichuan. The raw material is collected in autumn. Dipsaci radix is 5–15 cm in length and 0.5–2 cm in diameter, with slightly twisted or twisted longitudinal wrinkles and furrows. It is greyish-brown or yellowish-brown in color. Dipsaci radix has a spicy, bitter, slightly sweet, then astringent taste.
2. Traditional and Historical Use
2.1 Traditional Chinese Medicine (TCM)
It was first mentioned in the Shennong's Classic of Materia Medica, which named it for its ability to "renew fractures and join bones." According to the ancient medical book Essentials of Materia Medica, Dipsacus asper Wall, widely known as "xuduan" in traditional Chinese medicine, has beneficial properties for kidney injury and can promote the healing of bone damage, hemostasis and tocolysis.
Dipsacus asper Wall. ex C.B. Clarke, a traditional Chinese herbal medicine, has long been used in China for the therapy of bone diseases (e.g. bone fracture, osteoporosis, rheumatic arthritis), traumatic hematoma, uterine bleeding, and those caused by the deficiency of liver and kidney.
In TCM theories, Dipsacus asper Wall. ex Henry can nourish the liver and kidney and strengthen the muscles and bones. The ancient practitioners widely used it in the treatment of orthopedic diseases; the plant's Chinese name has the meaning of healing broken bones.
In the realm of TCM gynecology, the root of Dipsacus asper Wall. ex Henry is a well-known herbal medicine named Dipsaci Radix (DR) for the clinical treatment of menoxenia, leucorrhea disorder, puerperal disorder, breast nodule, and other women's diseases. Particularly, DR was ranked as the first selective herb reported in clinical studies to prevent and treat miscarriages in Chinese women, and its effects for uterine bleeding and tocolysis during pregnancy were highlighted in traditional experience cumulated for thousands of years.
2.2 Processing Methods in TCM
There are three processing methods for DA, including diaphoretic processing, wine-processing, and salt-processing. Dipsaci radix can be subjected to diaphoretic-, salt-, and wine-processing methods. These processing steps are considered to modify the relative concentration of active constituents. Diaphoretic processing resulted in a drop in the content of asperosaponin VI, which was highly associated with the bone-protective effect of DA. Therefore, diaphoretic processing was not a suitable processing method for DA.
2.3 Korean Traditional Medicine
The genus Dipsacus has been used for centuries in Chinese and Korean folk medicines to treat bone (osteoporosis) and joint problems (rheumatic arthritis). In Korea, the drug material is included in the Korean Herbal Pharmacopoeia and the plant's preparations are known under regional variant names.
2.4 European Traditional Use (D. fullonum)
The medicinal use of wild teasel root is rooted in traditional European and Chinese herbal systems. Historically, European herbalists used root preparations to treat various skin conditions, including warts and ulcers, and as a diuretic and stomachic. It was also used to clear liver obstructions and treat jaundice.
The principal medieval uses of wild teasel were medicinal. In the De Materia Medica (Book III.13), the ancient herbalist Dioscorides groups teasel with other prickly plants of the thistle tribe. The plant also had an important industrial history: historically, teasel was widely used in fiber processing as a natural comb to clean, align, and raise the nap of fabrics, especially wool.
2.5 Use in Lyme Disease (Contemporary Folk Application)
In actual ethnobotanical approaches, herbal medicines are involved, such as treatment with hydroethanolic extracts of teasel, obtained from the roots of Dipsacus sylvestris Huds., although antibacterial effects of the European teasel had not been described before such investigations. The most prominent contemporary claim involves its use as a supportive therapy for chronic conditions, particularly Lyme disease. Some herbalists propose that teasel helps the body manage the effects of the Borrelia burgdorferi spirochete. They theorize that the root's components may "wake up" dormant bacteria, making them more susceptible to the immune response or other treatments. This modern application is based primarily on anecdotal evidence and traditional practices, not rigorous scientific validation. Systematic reviews and major medical organizations do not recognize teasel as a recommended treatment for Lyme disease.
3. Phytochemistry: Key Constituents and Active Compounds
Until now, about one hundred components had been isolated from DA, which contains triterpenoids, iridoids, phenolic acids, essential oils, alkaloids, lignin, and fatty acids. More than 100 compounds have been isolated and identified from Dipsacus asper Wall. ex C.B. Clarke, a substantial proportion of which were reported to be triterpenoids and iridoids.
3.1 Triterpenoid Saponins
The most pharmacologically important chemical class isolated from Dipsacus is the triterpenoid saponins. Saponins are the primary effective components of the teasel root and 18 types of triterpenoid saponins have been isolated to date. The most extensively studied saponin is asperosaponin VI (also referred to as Akebia Saponin D, ASD, or ASA VI). Asperosaponin VI (ASA VI), also known as Akebia Saponin D (ASD), is the main bioactive component of the TCM Radix Dipsaci. The Chinese Pharmacopoeia specifies a minimum ASA VI content as a Dipsacus asper Wall quality standard.
Asperosaponin VI has various beneficial properties including neuroprotection, prevention of osteoporosis, protection against myocardial infarction, anti-apoptosis, and analgesia properties.
3.2 Iridoid Glycosides
Bioassay-guided fractionation of 95% EtOH extract from the roots of Dipsacus asper led to the isolation of iridoid glucoside dimers and monomers, along with known iridoid glycosides such as loganin, cantleyoside, triplostoside A, lisianthioside, and 6'-O-β-D-apiofuranosyl sweroside. Five iridoid compounds — loganic acid, loganin, sweroside, cantleyoside, and sylvestroside III — were identified in Dipsacus fullonum L. leaves and roots.
3.3 Phenolic Acids
Phenolic acids identified in D. asper roots include caffeic acid, 2,6-dihydroxycinnamic acid, vanillic acid, 2'-O-caffeoyl-D-glucopyranoside ester, and caffeoylquinic acid, which were described as major active components in bioassay-guided fractionation. Seven phenolic acids and three flavones were identified in the leaves of D. fullonum, and seven phenolic acids were detected in the roots.
3.4 Other Constituents
From the crude MeOH fraction of Dipsacus asper, compounds have been isolated and identified as sucrose, beta-sitosterol, oleanic acid, triplostoside A, loganin, loganin acid, sweroside, epi-vogeloside, vogeloside, akebiasaponin D, cauloside A, and 7-deoxyloganic acid. D. asper dominantly contains triterpenoid saponins, alkaloids (mainly lorcholine), iridoids, volatile oil, sitosterol, daucosterol, and trace elements (including Ca, Fe, Mg, Mn, Zn, and Cu).
These plants are rich sources of many valuable specialized metabolites with beneficial medicinal properties, such as triterpenoid derivatives, iridoids, phenolic acids, and flavonoids.
Regarding fatty acids, the presence of fatty acids has only been investigated in D. asper roots. Thirteen fatty acids including saturated and unsaturated acids have been identified.
4. Mechanisms of Action
4.1 Bone and Skeletal Mechanisms
Asperosaponin VI (ASA VI) is a kind of saponin in the medicinal herb Dipsacus asper Wall which has long been used as an anti-osteoporosis drug. The assay of cell proliferation, alkaline phosphatase (ALP) activity, and measurement of mineralized matrix showed that ASA VI exhibited significant induction of proliferation, differentiation, and mineralization in MC3T3-E1 and primary osteoblastic cells.
The result showed that ASA VI with the concentration lower than 10−4 M contributed to the expression of osteogenic genes and inhibited osteoclastic genes RANKL of BMSCs. Simultaneously, ASA VI significantly reduced the differentiation of mononuclear osteoclasts in the process of osteoclast formation induced by M-CSF and RANKL.
Studies revealed that ASA VI could inhibit adipogenic differentiation of preadipocyte 3T3-L1 and mouse bone marrow stromal cells ST-2. Furthermore, ASA VI was found to be effective in promoting bone marrow stem cell proliferation and osteogenic differentiation and inhibiting osteoclast absorption.
Studies have found that Radix Dipsaci functions by inhibiting osteoclast differentiation, preventing osteoporosis, and promoting fracture healing. Numerous signaling pathways are regulated by ASA VI, including the PI3K/AKT, HIF-1a/VEGF, p38, ERK1/2, and smad2/3 pathways.
4.2 Neuroprotective Mechanisms
D. asper extract was shown to potentially act as an antioxidant — with an effectiveness comparable to vitamin E — and protects against aluminum chloride toxicity by protecting cells and reducing Aβ expression in the hippocampus. Hydrogen peroxide-induced toxicity in the SH-SY5Y human neuroblastoma cell line is reduced by (−)-3,5-dicaffeoylmucoquinic acid and (−)-3,4-dicaffeoyl-muco-quinic acid (derived from D. asper) owing to an increase in SOD and catalase activity.
4.3 Anti-inflammatory and Antioxidant Mechanisms
Long-term gavage of akebia saponin D protected against fibrosis myocardial ischemia injury, inhibited cardiac dysfunction, and reduced infarct size in a Sprague-Dawley rat model with chronic myocardial infarction. Treatment with this saponin decreased hydroxyproline level and changed the activity of oxidative stress enzymes by elevating SOD and GSH-Px levels and reducing MDA content. Moreover, akebia saponin D regulated inflammatory mediators by diminishing the levels of TNF-α and IL-6 and elevating the level of IL-10.
4.4 Uterine and Reproductive Mechanisms
Radix Dipsaci total alkaloids can significantly inhibit the spontaneous contractile activity of uterine smooth muscle in pregnant rats and improve immune function. Asperosaponin VI, obtained from Radix Dipsaci, could promote decidualization by activating progesterone receptor expression and the Notch signaling pathway, which contributes to fetal protection.
4.5 Anticholinesterase Activity
Researchers evaluated the antiacetylcholinesterase (AChE) activities of Dipsacus fullonum L. leaves and roots. Roots showed stronger antiacetylcholinesterase activity than leaves, while leaf extract demonstrated the strongest antioxidant activity.
5. Scientific Evidence by Area of Use
5.1 Bone Health: Osteoporosis and Fracture Healing
This is the area with the most substantial body of preclinical research. Biological effects such as protective effects against bone fracture, anti-osteoporosis, neuroprotective, cardioprotective, anti-aging, and protection of reproductive system activities were evaluated in vitro and in vivo.
A series of in vitro studies has examined the effects of asperosaponin VI and total saponin fractions on osteoblast and osteoclast behavior. ASA VI exhibited significant induction of proliferation, differentiation, and mineralization in MC3T3-E1 and primary osteoblastic cells. Studies also demonstrated effects in animal models: Dipsacus extract was found to prevent the mass loss of OVX-induced bone and deterioration of trabecular microarchitecture.
In a study specifically examining signaling pathways, Niu et al. (2011) demonstrated that asperosaponin VI, a saponin component from Dipsacus asper Wall, induces osteoblast differentiation through the bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway.
Research on intervertebral disc degeneration examined whether ASA VI could support nucleus pulposus regeneration. A study investigated the role of ASA VI, isolated from the root of Dipsacus asper Wall, in promoting human mesenchymal stem cell (HMSC) proliferation and differentiation into NP-like cells and explored the possible mechanism of action. Effects of ASA VI on HMSC viability and proliferation were determined, and real-time qPCR, immunocytochemistry, and immunofluorescence assays were used to measure the effect on expression of extracellular matrix components including COL2A1, aggrecan, SOX9, KRT19, PAX1, and glycosaminoglycans in NP cells.
Evidence quality: The bone-related evidence is predominantly preclinical (in vitro cell cultures and animal models, chiefly rats and rabbits). Although Dipsacus asper Wall. ex C.B. Clarke was traditionally used for therapy of osteoarthritis, the in-depth study of the underlying mechanism was very rare. Much endeavor had been made on the effect of DA on bone fracture, but as of the most recent comprehensive review, no large-scale randomized controlled human trials have been published specifically isolating Dipsacus as a monotherapy for osteoporosis or fracture healing.
5.2 Osteoarthritis and Joint Health
Dipsacus saponins have been studied for chondrocyte effects relevant to osteoarthritis. It has been demonstrated that the Chinese teasel root promotes the proliferation and differentiation of osteoblasts, and is able to regulate immune function, indicating that it may be used to treat arthritis. A study in a rabbit osteoarthritis model examined the molecular mechanism of treating OA with Dipsacus saponins by inhibiting chondrocyte apoptosis. Chondrocytes were isolated and divided into groups treated with varying concentrations of Dipsacus saponins: 0, 25, 50, and 100 µg/L. Cell cycle distribution was analyzed using flow cytometry, and changes in cyclin D1, CDK4, p21, Bcl-2, Bax, caspase-3, and caspase-9 mRNA were detected.
Evidence quality: Evidence for osteoarthritis is largely preclinical (animal models and cell studies). Clinical human data is lacking for monotherapy applications.
5.3 Neuroprotection and Cognitive Function
An important area of preclinical research concerns Dipsacus extracts and their neuroprotective potential, specifically in relation to Alzheimer's disease-associated pathology. Researchers sought to evaluate the protective effects of Dipsacus asper extract against cognitive impairment and overexpression of hippocampal beta-amyloid protein (Aβ) induced by chronic aluminum exposure in rats. Vitamin E was used as a positive control. Following exposure to 0.3% aluminum chloride solution for 90 days, animals displayed a striking decrease (>80%) in step-through latency in the passive avoidance task and a significant increase (123%) in the number of Aβ immunoreactive cells in the hippocampus. Al-exposed animals were then randomly assigned to receive vehicle, Dipsacus asper extract (4 g/kg), or VE (40 mg/kg) treatment up to 5 months.
A further study examined the key bioactive compound Akebia Saponin D (ASD) in an Alzheimer's disease rat model. The study investigated the protective effects of ASD, isolated from the rhizome of Dipsacus asper Wall, on Aβ1–42-induced impairment of learning and memory formation. Treatment with ASD (30, 90, or 270 mg/kg) significantly ameliorated impaired spatial learning and memory in intracerebroventricularly Aβ1–42-injected rats, as evidenced by a decrease tendency in escape latency during acquisition trials and improvement in exploratory activities in the probe trial in Morris Water Maze.
Evidence quality: All neuroprotection evidence is from animal and cell-based (preclinical) studies. Although these phytochemicals have attracted attention owing to their in vitro neurotrophin potentiating activity, their in vivo and clinical efficacy trials have yet to be established. Therefore, further research is necessary to prove the neuroprotective effects in preclinical models and in humans. No human clinical trials on Dipsacus and neurodegeneration have been published.
5.4 Reproductive System: Threatened Abortion and Tocolysis
Pharmacological studies in recent decades have shown that Dipsaci Radix has a variety of biological activities, including antiuterine contraction, antiinflammatory, antiaging, antiarthritic, antiosteoporosis, fracture healing, and neuroprotection, and it has been verified to benefit Chinese women from miscarriages, serving as the preferred herb in clinical treatment. According to Chinese Pharmacopoeia 2020 edition, Dipsaci Radix exerts effects on tocolysis and uterine bleeding during pregnancy, which has been an accumulated experience for thousands of years.
The active components isolated from Dipsaci Radix, mainly saponins, triterpenes, volatile oils, and alkaloids, may have curative effects on female reproductive disorders through significantly suppressing the spontaneous contractions of the gestational uterus induced by oxidative toxins.
Evidence quality: The tocolytic and anti-abortion applications have pharmacopoeial recognition (Chinese Pharmacopoeia 2020) based on long accumulated clinical experience in TCM. Modern pharmacological studies provide mechanistic plausibility. However, rigorous blinded randomized controlled trials meeting current Western standards of clinical evidence are limited, and the evidence base remains primarily traditional use with supporting preclinical pharmacology.
5.5 Antimicrobial Activity
The current scientific literature data indicate that these plants and their constituents have various biological properties, including inter alia antiarthritic, anti-neurodegenerative, anti-inflammatory, antioxidant, anticancer, and antimicrobial activities; they have also been found to strengthen tendon and bone tissue and protect the liver, heart, and kidney. The essential oils possess antibacterial, antifungal, and insecticidal properties.
Researchers evaluated the antimicrobial (anti-bacterial and anti-yeast), antioxidant (ORAC methods), and antiacetylcholinesterase (AChE) activities of Dipsacus fullonum L. leaves and roots.
Specifically concerning Lyme disease, an in vitro investigation assessed whether extracts of D. sylvestris (synonymous with D. fullonum) had effects against Borrelia burgdorferi. Such ethnobotanical approaches have involved treatment with hydroethanolic extracts of teasel obtained from the roots of Dipsacus sylvestris Huds., although antibacterial effects of the European teasel had not been described before. Evidence quality: Preclinical and in vitro only. No human clinical data exists confirming efficacy against Lyme disease or any other specific infectious pathogen.
5.6 Cardioprotective Effects
Long-term gavage of akebia saponin D protected against fibrosis, myocardial ischemia injury, inhibited cardiac dysfunction, and reduced infarct size in a Sprague-Dawley rat model with chronic myocardial infarction. Treatment with this saponin decreased hydroxyproline level and changed the activity of oxidative stress enzymes by elevating SOD and GSH-Px levels and reducing MDA content. Moreover, akebia saponin D regulated inflammatory mediators by diminishing TNF-α and IL-6 levels and elevating IL-10.
Evidence quality: Animal model data only. No human clinical trials on cardioprotection have been published.
5.7 Anti-inflammatory and Hepatoprotective Activity
In the past decades, pharmacological studies on DA indicated the herb exhibited diverse bioactivities, including anti-osteoporosis, fracture healing, neuroprotective, anti-uterine contraction, anti-aging, hepatoprotective, anti-myocardial infarction, anti-inflammatory, and anti-arthritis.
Evidence quality: Predominantly in vitro and animal studies. The anti-inflammatory and hepatoprotective effects have been demonstrated in preclinical models, but clinical trials in humans are not available in the peer-reviewed literature to date.
6. Body Systems and Associated Health Areas
- Musculoskeletal system: Osteoporosis, bone fracture healing, rheumatic arthritis, joint pain, knee pain, low back pain, tendon and ligament repair
- Reproductive system: Threatened miscarriage, tocolysis, uterine bleeding, menstrual disorders, leucorrhea, puerperal disorders
- Central nervous system: Neuroprotection, cognition, Alzheimer's-associated amyloid pathology (preclinical)
- Cardiovascular system: Protection against myocardial infarction, anti-ischemic effects (preclinical)
- Liver: Hepatoprotective effects (preclinical)
- Immune and inflammatory system: Anti-inflammatory, modulation of TNF-α, IL-6, and IL-10
- Antimicrobial: Antibacterial, antifungal (essential oils; in vitro)
As summarized in a major review, modern pharmacological studies revealed that DA exhibited the effects of fracture healing, anti-osteoporosis, neuroprotective, anti-uterine contraction, anti-aging, hepatoprotective, anti-myocardial infarction, anti-inflammatory, and anti-arthritis.
7. Dosage Forms and Reported Dosages
7.1 Forms of Administration
Radix Dipsaci is most commonly administered as the dried root, and it can be prepared in various pharmaceutical forms:
- Decoctions: The dried root is boiled in water to produce a tea or concentrated liquid. This is the classical TCM form of administration.
- Tinctures/hydroethanolic extracts: Root material extracted in ethanol/water mixtures, used in European herbalism and some contemporary supplement products.
- Encapsulated dried extracts and standardized tablets: Contemporary supplement forms typically standardized to asperosaponin VI content per the Chinese Pharmacopoeia.
- Wine-processed and salt-processed forms: Traditional TCM processing methods that alter the phytochemical profile and are used for specific therapeutic indications. The anti-osteoporosis efficacy of salt-processed RD was stronger than that of raw RD, and the pharmacologically active ingredients that improved its anti-osteoporosis efficacy after processing with salt were caffeic acid, loganin, isochlorogenic acid C, and dipsanoside A.
7.2 Dosages Reported in Studies
The following dosages appear in the reviewed scientific literature:
- In the rat cognitive/neuroprotection study, Dipsacus asper extract was administered at 4 g/kg (compared with Vitamin E at 40 mg/kg).
- In the ASD/Alzheimer's rat model, treatment with ASD (30, 90, or 270 mg/kg) significantly ameliorated impaired spatial learning and memory.
- In the subchronic toxicity study, RD water extract was administered orally to rats at doses of 0, 125, 250, 500, 1000, and 2000 mg/kg body weight/day for 13 weeks.
- In the embryotoxicity study, DR aqueous extracts at dosages of 8 or 32 g/kg/d (4.3 or 17.2 folds of the recommended daily dosage for adult humans, respectively) were studied for adverse impacts in maternal health and embryo-fetal development.
- In the osteoarthritis chondrocyte study, dipsacus saponins were administered at 0, 25, 50, and 100 µg/L in cell culture.
No human clinical pharmacokinetic dosing studies have been identified in this review that establish evidence-based dosage guidelines for the general population.
8. Safety Considerations
8.1 General Toxicology (Preclinical)
Despite ethnomedicinal benefits, there is very little information regarding in vivo toxicity or adverse effects of Radix Dipsaci. In the subchronic toxicity study, RD water extract was administered orally to rats at doses of 0, 125, 250, 500, 1000, and 2000 mg/kg body weight/day for 13 weeks. During the treatment period there were no mortalities attributed to RD-wE. Moreover, no toxic effects were observed with regard to body weight, clinical pathology (hematology, clinical biochemistry, and urinalysis), and anatomic pathology (gross findings, organ weight, and microscopic examination).
The changes related to the treatment were excessive salivation at the mouth and soft feces, observed in male and female rats at 1000 or 2000 mg/kg bw/day, but these were not accompanied by any microscopic correlate or other pathophysiological changes. Based on these results, the oral no-observed-adverse-effect level (NOAEL) of the RD water extract was considered to be 2000 mg/kg bw/day in both genders, although the target organs were not determined under the current experimental conditions.
8.2 Embryotoxicity and Pregnancy
This is a significant and documented safety concern. Despite the plant's traditional use in threatened miscarriage and gynecological conditions, high-dose use is associated with embryotoxic risk. DR aqueous extracts at the dosage of 8 or 32 g/kg/d (4.3 or 17.2 folds of the recommended daily dosage for adult humans, respectively) might cause adverse impacts in maternal health and embryo-fetal development. It suggests that high-dose and long-term administration of DR preparations should be unsafe to pregnant women.
Notably, high-dose Dipsacus asper administration may cause adverse impacts in maternal health and embryo-fetal development. This finding represents a paradox in the plant's use: while traditional and pharmacopoeial sources cite it for threatened miscarriage prevention at therapeutic doses, supratherapeutic doses appear embryotoxic in animal models.
8.3 Mycotoxin Contamination Risk
The dry root of Radix Dipsaci Wall is a Chinese herbal medicine for which exposure limits have not been defined because no data exist on its contamination with mycotoxins, even though it is highly susceptible to contamination with soil fungi during its growth. This represents an identified quality and safety gap in the current regulatory framework for this botanical material.
8.4 Processing Method and Constituent Variation
Diaphoretic processing resulted in a drop in the content of asperosaponin VI, which was highly associated with the bone-protective effect of DA. Therefore, diaphoretic processing was not a suitable processing method for DA. This highlights that the safety and efficacy profile of Radix Dipsaci preparations may vary significantly depending on processing methodology.
8.5 Authenticity and Species Identification
DNA barcoding has become a crucial step in clarifying the taxonomic identities of pharmacopoeial species, ensuring that evaluations of their pharmacological efficacy and safety are based on correctly identified species. Misidentification of species is a recognized concern in the supply chain for this botanical material.
8.6 Limitations of the Evidence Base
Direct comparison with traditional dosing is complicated by pharmacokinetic and metabolic differences. Future studies should aim to integrate estimated human-equivalent doses and pharmacokinetic parameters to evaluate whether the observed in vitro effects correspond to clinically meaningful levels.
References
Go back